Fortune December 14, 2022
Bob Kocher and Bryan Roberts

Welcome back to predictions season. We are pleased to share what we see in our still murky, and materially more dinged-up, crystal ball for 2023. But first, let’s look back and see how we did with our 2022 predictions.

In 2022, we scored 7 out of 10, approaching our previous high-water mark of 8 out of 10 in 2021. We also want to note that one of our evergreen predictions–namely, nothing would happen on drug prices–was an epic fail after the passage of the Inflation Reduction Act.

Additionally, we did not predict that we would all wake up to 1970s-style inflation and a Fed hiking cycle. This caused a sudden end to…well, just about everything: growth financings,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Insurance, Investments, Medicare Advantage, Mergers & Acquisitions / JV, Patient / Consumer, Payer, Provider, Technology, Telehealth, Trends
Sam Altman says the kid he’s expecting soon will never be smarter than AI, but thinks this ability will be valuable
Data Storage And Memory Powers AI At The 2025 CES
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
California county agrees to buy hospital in $150M deal
Insurer-PBM Firms Dominate Medicare Part D Market, Steering Patients to Their Pharmacies

Share This Article